ClinicalTrials.Veeva

Menu

Bupivacaine and Epinephrine Injection Study

A

Amin Javer

Status and phase

Enrolling
Phase 3
Phase 2

Conditions

Sinus Disease
Bleeding
Anesthesia

Treatments

Other: Sham injection
Drug: Sensorcaine with Epinephrine

Study type

Interventional

Funder types

Other

Identifiers

NCT06456255
H24-01167

Details and patient eligibility

About

Endoscopic sinus surgery (ESS) is a common otolaryngologic procedure that aims to remove the partitions that separate the sinus cavities, remove inflamed tissue, and optimize the sinuses for topical medication use. In this procedure, the surgeon will inject a combination of drugs, local anesthetics, and vasoconstrictors, to reduce bleeding and improve visualization. However, previous studies have shown similar results when injected with only saline. In this study, investigators want to determine if the injection of local anesthesic+vasoconstrictor compared to no injection at all makes any difference in improving the surgeon's visualization during an ESS.

Enrollment

80 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 19 years or older
  • Scheduled for primary ESS (including septoplasty)

Exclusion criteria

  • Cystic fibrosis
  • Systemic vasculitis or any bleeding disorders
  • Known or suspected hypersensitivity to bupivacaine or epinephrine
  • Previous sinus surgery
  • Inhaled drug use (i.e., cocaine) in the preceding 6 months
  • Nasal tumors
  • Patients on antiarrhythmics.
  • Patients with history of severe liver illness.
  • Patients identified as high-risk for complications during preoperative assessment with the anesthesiologist (e.g. untreated hypertension, ischemic heart disease, cerebral vascular insufficiency, heart block, peripheral vascular disorder, uncontrolled hyperthyroidism and diabetes)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups, including a placebo group

Injection
Experimental group
Description:
- Injection 0.25% bupivacaine with 1:200,000 epinephrine
Treatment:
Drug: Sensorcaine with Epinephrine
Sham injection
Placebo Comparator group
Description:
- Sham injection (only puncture, no injecting anything)
Treatment:
Other: Sham injection

Trial contacts and locations

1

Loading...

Central trial contact

Amin Javer

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems